Document 99bOpzLX1x4O4ZdRBBZ9GQg7p

Message From: Sent: To: Subject: Michael Dourson [dourson@tera.org] 3/9/2018 2:29:54 PM mail@sabinebonneck.de; aimin.chen@uc.edu; aroberson@coronaenv.com; jovanovic@risk-technologies.com; anatha.desikan@ici-group.com; akorchevskiy@c-ih.com; aseeley@dep.nyc.gov; athenakeene@aftonchemical.com; bneal@exponent.com; blester@wildflavors.com; Macler, Bruce [/o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=ee099ddcl2664019a8e5acec3ea2bbe3-BMACLER]; camile.jones@cincinnati-oh.gov; carolina.livi@agilent.com; daniel.newman@ks.gov; dproctor@toxstrategies.com; dcortes@statanalysis.com; elliot_howard@manchin.senate.gov; frank.hawkins@iucn.org; gabriel.knudsen@nih.gov; Woodall, George [/o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=a617aad87171414a8b9fca5ce395a899-Woodall, George]; g.kaptan@leeds.ac.uk; Jack Early [/o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=user767059ae]; james.s.smith454.civ@mail.mil; jane_macaulay@hc-sc.gc.ca; jcongleton@ewg.org; john.boll@caruscorporation.com; john.cummings@fmc.com; jmitchell@nsf.org; kshao@indiana.edu; karen.christian@uc.edu; Wagner, Kenneth [/o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=048236ab99bc4d5eal6cl39blb67719c-Wagner, Ken]; kshenry@thinet.com; lsteadha@idem.in.gov; ltrozzolo@trcsolutions.com; secretariat@scic.sg; lrecio@ils-inc.com; lcorey@intertox.com; murrislb@uc.edu; luisa.camacho@fda.hhs.gov; mandy.fung@hc-sc.gc.ca; mark_gibson@americanchemistry.com; miao-li@uiowa.edu; michael.zolandz@dentons.com; nancy.sauer@aecom.com; nsdeshmukh@intoxlab.com; nina.wang@gov.ab.ca; aawayemi@my.tnstate.edu; rswaffer@ihs.gmu.edu; ragnar.lofstedt@kcl.ac.uk;] j=x. 6 ldewoskin@etiologic.net [/o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=9a02e9e20b24407e9eb04112b2clecd4-rdewoskin@e]; rettinger@geosyntec.com; rogerdrew@toxconsult.com.au; ruhi.rezaaliyan@syngenta.com; ruth.roberts@apconix.com; smarnold@dow.com; slaughter@mbsdc.com; sergey.grinshpun@uc.edu; parvezs@iu.edu; shawn.sager@arcadis.com; siddhanti@endynna.com; sofiemiller@gwu.edu; sol@toxsciadvisors.com; sreedhar@liveonbiolabs.com; skoenigsberg@cecinc.com; sklaine@clemson.edu; sgilbert@innd.org; susana.viegas@estesl.ipl.pt; teresa.sterner.ctr@us.af.mil; obayashiy@ajiusa.com Rejoining TERA Dear Colleagues I am pleased to announce my return to the nonprofit 501c3 organization, Toxicology Excellence fo r Risk Assessment (TERA), as its Director o f Science. As many o f you know, TERA joined the University o f Cincinnati, College o f Medicine (https://fried,uc.edu/eh/centers/rsc) two years ago and became known as the Risk Science Center (RSC). Efowever, TERA always maintained an external nonprofit organization under the leadership o f Dr. Patricia McGinnis in order to complete several contracts, including one with the Consumer Products Safety Commission. TERA's Board o f Trustees has decided to continue TERA as a nonprofit organization and remain a separate entity from the RSC. TERA's mission will emphasize hazard identification, dose response assessment, independent peer review, and public education. Dr. McGinnis will continue to serve as TERA's President leading the business and contributing to projects as a board-certified toxicologist. As many o f you also know, TERA's extensive collaborative work was woefully mischaracterized during my US EPA confirmation hearings. Responses to this mischaracterization can be viewed at http://tera.org/TERAcollaborativework%2012,8.17.pdf. You may also wish to view https://www.cincinnati.com/stoiy/news/politics/2018/01/25/university-cincinnati-professorformer-uc-professor-dourson-picks-up-pieces-after-failed-controversi/1047685001/ for some additional thoughts on this confirmation process. Sierra Club v. EPA 18cv3472 NDCA Tier 2 ED 002061 00175324-00001 TERA looks forward to the opportunity to work with you in the future. If you are attending the annual meeting o f the Society o f Toxicology next month, please stop by our booth #555. Cheers! Michael... ...L. Dourson, Ph D., DABT, FATS, FSRA Director of Science t TERA Toxicology Excellence For Risk Assessment 1250 Ohio Pike, Suite #197 Amelia, Ohio 45102-1239 Email dourson@tera. org Twitter, com/mdourson Phond Ex. 6 L ____________________________________________________________ Fax 513.964.9472 Alt Phone i Ex. 6 Independent Non-Profit Science Sierra Club v. EPA 18cv3472 NDCA Tier 2 ED 002061 00175324-00002